title: IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease.
abstract: Immune escape is a fundamental trait of cancer in which the Th1-type cytokine interferon- γ (IFN-γ) seems to play a key role. Among other tumoricidal biochemical pathways, IFN-γ induces the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) in a variety of cells including macrophages, dendritic cells (DCs) and tumor cells. IDO activity has been shown to reflect the extent and the course in a plethora of malignancies including prostate, colorectal, pancreatic, cervical, endometrial, gastric, lung, bladder, ovarian, esophageal and renal cell carcinomas, glioblastomas, mesotheliomas, and melanomas. Furthermore IDO activity during malignant tumor diseases seems to be part of the tumoricidal immune defense strategy, which in the long run is detrimental to the host, when tryptophan deprivation and production of pro-apoptotic tryptophan catabolites counteract T-cell responsiveness.
authors.affiliation: Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery.
authors.forename: Robert
authors.initials: R
authors.lastname: Sucher
authors.forename: Katharina
authors.initials: K
authors.lastname: Kurz
authors.forename: Guenter
authors.initials: G
authors.lastname: Weiss
authors.forename: Raimund
authors.initials: R
authors.lastname: Margreiter
authors.forename: Dietmar
authors.initials: D
authors.lastname: Fuchs
authors.forename: Gerald
authors.initials: G
authors.lastname: Brandacher
references.citation: Virchows Arch. 2009 Nov;455(5):441-8
references.pmid: 19844741
references.citation: Int J Parasitol. 2004 Nov;34(12):1309-19
references.pmid: 15542091
references.citation: Int J Biochem Cell Biol. 2009 Mar;41(3):467-71
references.pmid: 18282734
references.citation: Nat Med. 2005 Mar;11(3):312-9
references.pmid: 15711557
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18619-24
references.pmid: 18003900
references.citation: Adv Exp Med Biol. 1996;398:285-9
references.pmid: 8906279
references.citation: Nat Rev Immunol. 2008 Jan;8(1):74-80
references.pmid: 18064049
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):6030-9
references.pmid: 16115948
references.citation: Infect Immun. 2002 Feb;70(2):779-86
references.pmid: 11796611
references.citation: J Biol Chem. 1975 Aug 10;250(15):5960-6
references.pmid: 238993
references.citation: J Biol Chem. 1988 Feb 5;263(4):2041-8
references.pmid: 3123485
references.citation: Lung Cancer. 2010 Mar;67(3):361-5
references.pmid: 19487045
references.citation: J Clin Invest. 2007 May;117(5):1147-54
references.pmid: 17476344
references.citation: Proc Natl Acad Sci U S A. 1988 Feb;85(4):1242-6
references.pmid: 3124115
references.citation: Cell Death Differ. 2002 Oct;9(10):1069-77
references.pmid: 12232795
references.citation: Gene. 2007 Jul 1;396(1):203-13
references.pmid: 17499941
references.citation: Immunity. 2005 May;22(5):633-42
references.pmid: 15894280
references.citation: J Immunol. 1993 Jun 15;150(12):5529-34
references.pmid: 8515074
references.citation: Int J Biol Markers. 2006 Jul-Sep;21(3):190-8
references.pmid: 17013802
references.citation: Immunology. 2002 Dec;107(4):452-60
references.pmid: 12460190
references.citation: Nat Rev Cancer. 2005 Apr;5(4):263-74
references.pmid: 15776005
references.citation: J Cancer Res Clin Oncol. 2008 Nov;134(11):1247-53
references.pmid: 18438685
references.citation: Cancer Immunol Immunother. 2009 Jan;58(1):153-7
references.pmid: 18418598
references.citation: J Exp Med. 2002 Aug 19;196(4):459-68
references.pmid: 12186838
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1144-51
references.pmid: 16489067
references.citation: Dermatology. 2007;214(1):8-14
references.pmid: 17191041
references.citation: Nat Med. 2007 May;13(5):579-86
references.pmid: 17417651
references.citation: Blood. 2008 Feb 15;111(4):2152-4
references.pmid: 18045970
references.citation: Cancer Lett. 2010 Jan 1;287(1):13-22
references.pmid: 19500901
references.citation: Oncogene. 2008 Jun 26;27(28):3889-900
references.pmid: 18317452
references.citation: J Immunol. 2006 Jun 1;176(11):6752-61
references.pmid: 16709834
references.citation: J Clin Invest. 2004 Jul;114(2):280-90
references.pmid: 15254595
references.citation: Haematologica. 2008 Dec;93(12):1894-8
references.pmid: 19050070
references.citation: Obstet Gynecol. 1996 Jul;88(1):47-50
references.pmid: 8684760
references.citation: Int J Gynecol Cancer. 2006 Jan-Feb;16(1):240-52
references.pmid: 16445639
references.citation: Int Immunol. 1996 Jun;8(6):855-65
references.pmid: 8671675
references.citation: Neoplasia. 2005 Apr;7(4):390-6
references.pmid: 15967116
references.citation: Nat Rev Cancer. 2009 Jun;9(6):445-52
references.pmid: 19461669
references.citation: Cancer Res. 2007 Jan 15;67(2):792-801
references.pmid: 17234791
references.citation: Curr Cancer Drug Targets. 2007 Feb;7(1):1
references.pmid: 17305473
references.citation: Cancer Res. 2007 Aug 1;67(15):7082-7
references.pmid: 17671174
references.citation: Adv Exp Med Biol. 2003;527:183-90
references.pmid: 15206731
references.citation: J Exp Med. 1999 May 3;189(9):1363-72
references.pmid: 10224276
references.citation: Cell Cycle. 2009 Jun 15;8(12):1930-4
references.pmid: 19448397
references.citation: Redox Rep. 1999;4(5):199-220
references.pmid: 10731095
references.citation: J Exp Med. 2002 Aug 19;196(4):447-57
references.pmid: 12186837
references.citation: Clin Chem. 1999 Nov;45(11):1998-2004
references.pmid: 10545071
references.citation: Br J Cancer. 2006 Dec 4;95(11):1555-61
references.pmid: 17117179
references.citation: Int J Cancer. 1998 Oct 23;79(5):476-80
references.pmid: 9761115
references.citation: Science. 1998 Aug 21;281(5380):1191-3
references.pmid: 9712583
references.citation: Annu Rev Immunol. 1993;11:571-611
references.pmid: 8476573
references.citation: Clin Cancer Res. 2007 Dec 1;13(23):6993-7002
references.pmid: 18056175
references.citation: Nat Immunol. 2003 Dec;4(12):1206-12
references.pmid: 14578884
references.citation: Clin Exp Metastasis. 2009;26(8):1005-12
references.pmid: 19802733
references.citation: Nat Med. 2003 Oct;9(10):1269-74
references.pmid: 14502282
references.citation: Int J Cancer. 2002 Sep 10;101(2):151-5
references.pmid: 12209992